Literature DB >> 21398508

Enzymatic dysfunction of mitochondrial complex I of the Candida albicans goa1 mutant is associated with increased reactive oxidants and cell death.

Dongmei Li1, Hui Chen, Abigail Florentino, Deepu Alex, Patricia Sikorski, William A Fonzi, Richard Calderone.   

Abstract

We have previously shown that deletion of GOA1 (growth and oxidant adaptation) of Candida albicans results in a loss of mitochondrial membrane potential, ATP synthesis, increased sensitivity to oxidants and killing by human neutrophils, and avirulence in a systemic model of candidiasis. We established that translocation of Goa1p to mitochondria occurred during peroxide stress. In this report, we show that the goa1Δ (GOA31), compared to the wild type (WT) and a gene-reconstituted (GOA32) strain, exhibits sensitivity to inhibitors of the classical respiratory chain (CRC), including especially rotenone (complex I [CI]) and salicylhydroxamic acid (SHAM), an inhibitor of the alternative oxidase pathway (AOX), while potassium cyanide (KCN; CIV) causes a partial inhibition of respiration. In the presence of SHAM, however, GOA31 has an enhanced respiration, which we attribute to the parallel respiratory (PAR) pathway and alternative NADH dehydrogenases. Interestingly, deletion of GOA1 also results in a decrease in transcription of the alternative oxidase gene AOX1 in untreated cells as well as negligible AOX1 and AOX2 transcription in peroxide-treated cells. To explain the rotenone sensitivity, we measured enzyme activities of complexes I to IV (CI to CIV) and observed a major loss of CI activity in GOA31 but not in control strains. Enzymatic data of CI were supported by blue native polyacrylamide gel electrophoresis (BN-PAGE) experiments which demonstrated less CI protein and reduced enzyme activity. The consequence of a defective CI in GOA31 is an increase in reactive oxidant species (ROS), loss of chronological aging, and programmed cell death ([PCD] apoptosis) in vitro compared to control strains. The increase in PCD was indicated by an increase in caspase activity and DNA fragmentation in GOA31. Thus, GOA1 is required for a functional CI and partially for the AOX pathway; loss of GOA1 compromises cell survival. Further, the loss of chronological aging is new to studies of Candida species and may offer an insight into therapies to control these pathogens. Our observation of increased ROS production associated with a defective CI and PCD is reminiscent of mitochondrial studies of patients with some types of neurodegenerative diseases where CI and/or CIII dysfunctions lead to increased ROS and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21398508      PMCID: PMC3127659          DOI: 10.1128/EC.00303-10

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  59 in total

1.  Molecular cloning and functional expression of alternative oxidase from Candida albicans.

Authors:  W K Huh; S O Kang
Journal:  J Bacteriol       Date:  1999-07       Impact factor: 3.490

2.  Kinetic characterization of the rotenone-insensitive internal NADH: ubiquinone oxidoreductase of mitochondria from Saccharomyces cerevisiae.

Authors:  I Velázquez; J P Pardo
Journal:  Arch Biochem Biophys       Date:  2001-05-01       Impact factor: 4.013

3.  The concomitant expression and availability of conventional and alternative, cyanide-insensitive, respiratory pathways in Candida albicans.

Authors:  Eva J Helmerhorst; Maria Stan; Michael P Murphy; Fred Sherman; Frank G Oppenheim
Journal:  Mitochondrion       Date:  2005-06       Impact factor: 4.160

4.  Mitochondrial dysfunction leads to reduced chronological lifespan and increased apoptosis in yeast.

Authors:  An M Aerts; Piotr Zabrocki; Gilmer Govaert; Janick Mathys; Didac Carmona-Gutierrez; Frank Madeo; Joris Winderickx; Bruno P A Cammue; Karin Thevissen
Journal:  FEBS Lett       Date:  2008-12-04       Impact factor: 4.124

Review 5.  Apoptosis in yeast: triggers, pathways, subroutines.

Authors:  D Carmona-Gutierrez; T Eisenberg; S Büttner; C Meisinger; G Kroemer; F Madeo
Journal:  Cell Death Differ       Date:  2010-01-15       Impact factor: 15.828

6.  Human hepatitis B virus-X protein alters mitochondrial function and physiology in human liver cells.

Authors:  Young Ik Lee; Jung Me Hwang; Jee Hye Im; Yoon Ik Lee; Nam Soon Kim; Dae Gon Kim; Dae Yeul Yu; Hyung Bae Moon; Sook Kyung Park
Journal:  J Biol Chem       Date:  2004-01-14       Impact factor: 5.157

7.  In Yarrowia lipolytica mitochondria, the alternative NADH dehydrogenase interacts specifically with the cytochrome complexes of the classic respiratory pathway.

Authors:  Sergio Guerrero-Castillo; Miriam Vázquez-Acevedo; Diego González-Halphen; Salvador Uribe-Carvajal
Journal:  Biochim Biophys Acta       Date:  2008-11-06

8.  Involvement of Candida albicans NADH dehydrogenase complex I in filamentation.

Authors:  Justin A McDonough; Vasker Bhattacherjee; Tania Sadlon; Margaret K Hostetter
Journal:  Fungal Genet Biol       Date:  2002-07       Impact factor: 3.495

9.  The membrane domain of complex I is not assembled in the stopper mutant E35 of Neurospora.

Authors:  P C Alves; A Videira
Journal:  Biochem Cell Biol       Date:  1998       Impact factor: 3.626

10.  Transcriptional regulation of carbohydrate metabolism in the human pathogen Candida albicans.

Authors:  Christopher Askew; Adnane Sellam; Elias Epp; Hervé Hogues; Alaka Mullick; André Nantel; Malcolm Whiteway
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

View more
  31 in total

Review 1.  Aging and cell death in the other yeasts, Schizosaccharomyces pombe and Candida albicans.

Authors:  Su-Ju Lin; Nicanor Austriaco
Journal:  FEMS Yeast Res       Date:  2013-11-08       Impact factor: 2.796

Review 2.  System-level impact of mitochondria on fungal virulence: to metabolism and beyond.

Authors:  Richard Calderone; Dongmei Li; Ana Traven
Journal:  FEMS Yeast Res       Date:  2015-05-21       Impact factor: 2.796

3.  Influence of phosphatidylserine and phosphatidylethanolamine on farnesol tolerance in Candida albicans.

Authors:  Sahar Hasim; Elyse N Vaughn; Dallas Donohoe; Donna M Gordon; Susan Pfiffner; Todd B Reynolds
Journal:  Yeast       Date:  2018-02-08       Impact factor: 3.239

Review 4.  Exploiting mitochondria as targets for the development of new antifungals.

Authors:  Dongmei Li; Richard Calderone
Journal:  Virulence       Date:  2016-05-18       Impact factor: 5.882

5.  Azole susceptibility and transcriptome profiling in Candida albicans mitochondrial electron transport chain complex I mutants.

Authors:  Nuo Sun; William Fonzi; Hui Chen; Xiaodong She; Lulu Zhang; Lixin Zhang; Richard Calderone
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

Review 6.  Functional diversity of complex I subunits in Candida albicans mitochondria.

Authors:  Dongmei Li; Xiaodong She; Richard Calderone
Journal:  Curr Genet       Date:  2015-09-15       Impact factor: 3.886

7.  Multidrug-resistant transporter mdr1p-mediated uptake of a novel antifungal compound.

Authors:  Nuo Sun; Dongmei Li; William Fonzi; Xin Li; Lixin Zhang; Richard Calderone
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

8.  Alternative Oxidase Promotes Biofilm Formation of Candida albicans.

Authors:  Ting-Mei Wang; Xiao-Hui Xie; Ke Li; Yun-Hua Deng; Hui Chen
Journal:  Curr Med Sci       Date:  2018-06-22

9.  Cell surface changes in the Candida albicans mitochondrial mutant goa1Δ are associated with reduced recognition by innate immune cells.

Authors:  Xiaodong She; Lulu Zhang; Hui Chen; Richard Calderone; Dongmei Li
Journal:  Cell Microbiol       Date:  2013-03-28       Impact factor: 3.715

10.  Mitochondrial two-component signaling systems in Candida albicans.

Authors:  John Mavrianos; Elizabeth L Berkow; Chirayu Desai; Alok Pandey; Mona Batish; Marissa J Rabadi; Katherine S Barker; Debkumar Pain; P David Rogers; Eliseo A Eugenin; Neeraj Chauhan
Journal:  Eukaryot Cell       Date:  2013-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.